Log in Register
Menu

MCF-7/AnaR-2 Cell Line

Invented by Dr Anne Lykkesfeldt at Danish Cancer Society

Info

Catalogue Number 152552
Antigen/Gene or Protein Targets Anastrozole resistance
Parental Line MCF7
Host Human
Tissue Breast
Disease Keywords Breast Cancer
Relevance The MCF7/AnaR-2 Cell Line was developed as a model of resistance to anti-cancer treatment with aromatase inhibitors. Third generation aromatase inhibitors (AIs) have proven to be effective treatment for estrogen receptor positive (ER+) breast cancer and are today recommended as first line endocrine therapy for postmenopausal ER+ breast cancer patients, making up the majority of breast cancer patients. However, a major problem is development of resistance against AIs. Since molecular mechanisms of AI resistance are largely undisclosed, the development of cell lines resistant to the non-steroidal AI anastrozole allows the study of the molecular basis for resistance to AIs to unravel new targets for treatment.
Production Details Anastrozole-resistant cell lines were established from MCF-7 cells grown in medium with 10% NCS and 10−7 M testosterone. A culture of MCF-7 cells were treated with 10−7 M anastrozole for one week, trypsinized and seeded in serial dilutions in 24-well plates. Single colonies were transferred to new wells and gradually expanded in medium with anastrozole. After ~2–3 months, the isolated colonies gave rise to anastrozole-resistant cell lines, which could be grown in anastrozole-containing medium with a weekly split ratio of ~1:25. The MCF-7 cell line was authenticated in January 2014 by DNA profiling using short tandem repeat loci and found to be matching the genetic profile reported for the MCF-7 cell line.
Conditional No
Research Area Cancer, Drug Discovery & Development
Growth/Phenotype Keywords Breast cancer cell line resistant to the aromatase inhibitor anastrozole. Estrogen receptor positive.
Recommended Growing Conditions Phenol-red-free DMEM/F12 medium supplemented with 10% newborn calf serum, 2.5 mM Glutamax, 6 ng/ ml insulin, 0.1 uM testosterone and 0.1 uM anastrozole.
Notes Human breast cancer cell line derived from MCF-7 cells
Other related cell lines:
- LetR-1, LetR-2, LetR-3 and LetR-4 resistant to the non-steroidal AI letrozole
- ExeR-1, ExeR-2, ExeR-3 and ExeR-4 resistant to the steroidal AI exemestane
- AnaR-1, AnaR-3 and AnaR-4 resistant to the non-steroidal AI anastrozole

Passage 431 (AL3977, AL3978)
Cellosaurus ID CVCL_5A10

References: 2 entries

Hole et al. 2015. Breast Cancer Res Treat. 149(3):715-26. PMID: 25667100.

Hole et al. 2015. Int J Oncol. 46(4):1481-90. PMID: 25625755.


Add a reference

References: 2 entries

Hole et al. 2015. Breast Cancer Res Treat. 149(3):715-26. PMID: 25667100.

Hole et al. 2015. Int J Oncol. 46(4):1481-90. PMID: 25625755.


Add a reference

References: 2 entries

Hole et al. 2015. Breast Cancer Res Treat. 149(3):715-26. PMID: 25667100.

Hole et al. 2015. Int J Oncol. 46(4):1481-90. PMID: 25625755.


Add a reference


This reagent does not have any reviews at the moment.